AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Evogene Ltd.

Regulatory Filings Nov 16, 2016

6785_rns_2016-11-16_4bdb7961-0751-4f92-86ee-dd9f60a89812.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

_________ false

����� ��"� 2 380
EVOGENE LTD
Corporation no: 512838723 10571
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 16/11/2016
www.isa.gov.il www.tase.co.il Reference: 2016-02-078987 Time of broadcast: 14:03 13:48:33

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Press Release: Evogene Announces Positive Field Trial Results in Ag-biologicals Program
6-K_Positive_Results_Ag-biologicals_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 31/10/2016
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected]   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Masliah Sassi Position of Signatory in the reporting corporation: Adv., Corporate Secretary Name of Employer Company:
Address: Eizenberg Aharon 19 , Rehovot 7629008 Telephone: 08-9311971 Facsimile: 08-9466724 E-mail: [email protected] 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.